Because adenine nucleotide catabolites may be important during postisc
hemic lung reperfusion, we examined the pathway of adenosine monophosp
hate (AMP) degradation in ischemic lung tissue. Once the pattern of de
gradation is known, pharmacological interventions can be considered, o
ffering new methods of reducing lung reperfusion injury. For this purp
ose we used the isolated rabbit lung. Rabbit lungs were flushed in sit
u with a modified Krebs Henseleit solution (60 ml/kg). The lungs were
removed and stored deflated immersed in saline solution at 37 degrees
C. At regular times, biopsies were taken, and adenine nucleotides, nuc
leosides, and bases were measured in these biopsies using high perform
ance liquid chromatography (HPLC). During lung ischemia, a very signif
icant increase of inosine monophosphate (IMP) was found Adenosine leve
ls on the other hand did not increase. Hypoxanthine was the major end
catabolite of ischemic lung tissue (constituting 92% of the nucleoside
and purine base fraction at 4 hours ischemia). To further determine t
he pathway of AMP degradation, 400 mM of the adenosine deaminase inhib
itor erythro-9-[2-hydroxy-3-nonyl]adenine (EHNA) was added to the lung
flush solution. During ischemia, adenosine triphosphate (ATP) breakdo
wn was unaltered but adenosine became the major catabolite (2.8 rimes
the concentration of hypoxanthine al 4 hours ischemia). These data sug
gest that: 1) in rabbit lung tissue, dephosphorlation of AMP to adenos
ine is more important than deamination to IMP; 2) hypoxanthine is the
major end catabolite of ischemic lung tissue. By inhibiting the enzyme
deaminase, reduced hypoxanthine levels and increased adenosine levels
were obtained Pharmacological interventions are now available to inte
rfere with the formation of adenine nucleosides and bases in ischemic
lung tissue. The importance of adenine nucleotide catabolites to posti
schemic lung reperfusion injury is discussed.